Pricing

GLENVIEW CAPITAL MANAGEMENT, LLC

11 followers · 2 likes
NEW YORK NY Investment Advisor Hedge Fund Billionaires Group Activist Investor
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Glenview Capital Management is based out of New York. Glenview Capital Management is a hedge fund with 5 clients and discretionary assets under management (AUM) of $4,771,330,575 (Form ADV from 2025-03-31). Their last reported 13F filing for Q1 2025 included $4,067,271,337 in managed 13F securities and a top 10 holdings concentration of 67.28%. Glenview Capital Management's largest holding is CVS Health Corp with shares held of 11,946,799. Whalewisdom has at least 97 13F filings, 39 13D filings, 319 13G filings, and 11 Form 4 filings
Business Description
Glenview's research efforts encompass a variety of activities to gather, assimilate, and analyze information about industries and companies. This helps them make fundamentally sound, intelligent investment decisions. Glenview’s investment team is structured by industry groups, which have the relevant experience and analytical framework to understand businesses. As part of managing the Clients’ portfolios, Glenview may try to secure the appointment of certain persons to the management or board of directors of a portfolio company. Glenview personnel are likely to acquire fiduciary duties to the portfolio company and to the portfolio company’s other shareholders. Glenview may have a conflict of interest between the fiduciary duties that its personnel owe to such company(ies) and its (their) shareholders, on the one hand, and those that.
Investment Strategy
Glenview employs a bottom-up, fundamental research process for its investments in equity and fixed income securities. This involves gathering, assimilating, and analyzing information about industries and companies to make informed investment decisions. The investment team is structured by industry groups, performing rigorous financial analysis and stress-testing models to identify potential scenarios. They also engage with various sources, including management teams, industry analysts, competitors, suppliers, and consultants, to gain industry-specific knowledge. The firm utilizes different strategies across its funds. The Glenview Funds employ a long/short strategy focused on investments in equity and fixed income securities. The Opportunity Funds use a purely opportunistic investment approach with no limits on positions, size, types of securities, or industry concentration. The Healthcare Funds employ a long/short strategy focused on investments in issuers operating in or adjacent to the healthcare industry.
Owners
  • RFH MANAGEMENT LLC - MEMBER
  • ROBBINS, LAWRENCE, MICHAEL - CEO, PORTFOLIO MANAGER & MANAGER
  • RODIN, JOHN, DAVID - CO-PRESIDENT
  • WEISS, JENNIFER, R - CHIEF FINANCIAL OFFICER
  • HOROWITZ, MARK, JOSEPH - CO-PRESIDENT, GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
  • Click on the Ownership/Private Fund Data tab for more details.
Known Email Addresses
(Subscription Required)
Other Contact Information
(Subscription Required)

2025-03-31

Top Buys (13F)

2025-03-31

Top Sells (13F)

2025-03-31

13F Holdings Summary

Name $ Change
CVS CVS Health Corp 19.9%
THC Tenet Healthcare Cor 11.23%
GPN Global Payments Inc 9.13%
TEVA Teva Pharmaceutical 5.58%
ALIT Alight Inc 4.77%

2025-03-31

13F Activity

Market Value $4.07b, Prior: $3.96b
Inflows (Outflows) as % of Total MV +2.276%
New Purchases 14 stocks
Added To 13 stocks
Sold out of 5 stocks
Reduced holdings in 13 stocks
Top 10 Holdings % 67.28%
Turnover %[1] 38%
Turnover Alt %[2] 13.83%
Time Held Top 20 8 quarters
Time Held Top 10 9.9 quarters
Time Held All 11.13 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2025-03-31

13F Sector Allocation Over Time

limited to past 4 quarters. Subscribe to see all available data

2025-03-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2025-03-31

Portfolio Performance